NCT01599507 - Study of FG-4592 in Subjects With Chronic Kidney Disease in China | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Anemia in Chronic Kidney Disease

Interventions

DRUG

FG-4592

TIW dosing, capsule

DRUG

Placebo

TIW dosing, capsule

Trial Locations (13)

Peking Union Medical College Hospital, Beijing

Peking University First Hospital, Beijing

Sichuan Provincial People's Hospital, Chengdu

West China Hospital, Chengdu

First affiliated hospital of Dalian medical university, Dalian

First Affiliated Hospital, Sun Yat-Sen University, Guangzhou

Zhejiang University No 1. Hospital, Hangzhou

Chang Zheng Hospital, Shanghai

Huashan Hospital, Shanghai

Renji Hospital, Shanghai

RuiJin Hospital, Shanghai

XinHua Hospital, Shanghai

Shenzhen People's Hospital, Shenzhen